Overall Survival Advantage through Ribociclib for premenopausal Women with metastatic Breast Cancer

被引：0
|
作者：
Ruckhaeberle, E. [1 ]
机构：
[1] Univ Frauenklin Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany
来源：
ONKOLOGE | 2020年 / 26卷 / 07期
关键词：
D O I：
10.1007/s00761-020-00726-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：656 / 657
页数：2
相关论文
共 50 条
  • [1] Gesamtüberlebensvorteil durch Ribociclib für prämenopausale Frauen mit metastasiertem MammakarzinomOverall survival advantage through ribociclib for premenopausal women with metastatic breast cancer
    E. Ruckhäberle
    [J]. Der Onkologe, 2020, 26 (7): : 656 - 657
  • [2] Ribociclib in premenopausal women with advanced breast cancer
    Foukakis, Theodoros
    [J]. LANCET ONCOLOGY, 2018, 19 (07): : 850 - 852
  • [3] SURVIVAL OF PREMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER
    FALKSON, G
    GELMAN, RS
    LEONE, L
    ROSSOF, AH
    FALKSON, CI
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 197 - 197
  • [4] Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
    Hortobagyi, Gabriel N.
    Stemmer, Salomon M.
    Burris, Howard A.
    Yap, Yoon-Sim
    Sonke, Gabe S.
    Hart, Lowell
    Campone, Mario
    Petrakova, Katarina
    Winer, Eric P.
    Janni, Wolfgang
    Conte, Pierfranco
    Cameron, David A.
    Andre, Fabrice
    Arteaga, Carlos L.
    Zarate, Juan P.
    Chakravartty, Arunava
    Taran, Tetiana
    Le Gac, Fabienne
    Serra, Paolo
    O'Shaughnessy, Joyce
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10): : 942 - 950
  • [5] Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
    Im, S. -A.
    Lu, Y. -S.
    Bardia, A.
    Harbeck, N.
    Colleoni, M.
    Franke, F.
    Chow, L.
    Sohn, J.
    Lee, K. -S.
    Campos-Gomez, S.
    Villanueva-Vazquez, R.
    Jung, K. -H.
    Chakravartty, A.
    Hughes, G.
    Gounaris, I.
    Rodriguez-Lorenc, K.
    Taran, T.
    Hurvitz, S.
    Tripathy, D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04): : 307 - 316
  • [6] Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
    Slamon, Dennis J.
    Neven, Patrick
    Chia, Stephen
    Fasching, Peter A.
    De Laurentiis, Michelino
    Im, Seock-Ah
    Petrakova, Katarina
    Bianchi, Giulia V.
    Esteva, Francisco J.
    Martin, Miguel
    Nusch, Arnd
    Sonke, Gabe S.
    De la Cruz-Merino, Luis
    Beck, J. Thaddeus
    Pivot, Xavier
    Sondhi, Manu
    Wang, Yingbo
    Chakravartty, Arunava
    Rodriguez-Lorenc, Karen
    Taran, Tetiana
    Jerusalem, Guy
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (06): : 514 - 524
  • [7] Duration of signs and survival in premenopausal women with breast cancer
    Love, RR
    Duc, NB
    Baumann, LC
    Anh, PTH
    Van To, T
    Qian, Z
    Havighurst, TC
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 86 (02) : 117 - 124
  • [8] Duration of Signs and Survival in Premenopausal Women with Breast Cancer
    Richard R. Love
    Nguyen Ba Duc
    Linda C. Baumann
    Pham Thi Hoang Anh
    Ta Van To
    Zheng Qian
    Thomas C. Havighurst
    [J]. Breast Cancer Research and Treatment, 2004, 86 : 117 - 124
  • [9] Association between duration of ovarian function suppression and overall survival in premenopausal women with early breast cancer
    Altundag, Kadri
    [J]. JOURNAL OF BUON, 2020, 25 (02): : 1267 - 1267
  • [10] MASSIVE ESTROGEN ADMINISTRATION IN PREMENOPAUSAL WOMEN WITH METASTATIC BREAST CANCER
    KENNEDY, BJ
    [J]. CANCER, 1962, 15 (03) : 641 - &
12345